Clinical Trial Update: Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating schedules of donor-derived viral-specific T-cells to treat viral infections after allogeneic stem cell transplantation; curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Viral Infection

Drugs mentioned

• Donor-Derived Viral Specific T-cells

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Allogeneic Stell Cell Transplant, Viral Infection | Phase 2 | Status: RECRUITING